Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter Clinical Trial Designed to Evaluate the Safety and Performance of the AqueSys XEN 45 Glaucoma Implant in Subjects With Refractory Glaucoma

NCT02036541 is registered in ClinicalTrials.gov with AqueSys, Inc. as lead sponsor.

NCT NCT02036541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02036541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter Clinical Trial Designed to Evaluate the Safety and Performance of the AqueSys XEN 45 Glaucoma Implant in Subjects With Refractory Glaucoma
Lead sponsor
AqueSys, Inc.
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2013
Completion date
August 31, 2016
Enrollment
65 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma, glaucoma, open angle